Tag Archives: Yasmin

Reglan most litigated drug of 2011, latest ranking says

The anti-nausea drug Reglan and its generic counterparts were the drugs most frequently cited in litigation in 2011, according to a consumer watchdog’s latest analysis of Food and Drug Administration statistics.

Read More »

Watchdog cites conflicts in calling for new Yaz panel

An independent watchdog group has asked the Food and Drug Administration to disregard a safety panel’s recommendation to keep the popular birth control drugs Yaz and Yasmin on the market, citing evidence that several panel members operated under conflicts of ...

Read More »

Yaz plaintiff loses bid to unseal documents for FDA

The Food and Drug Administration will not be given access to documents relating to the safety of drospirenone-containing oral contraceptives that pharmaceutical company Bayer has kept confidential in the Yaz and Yasmin multidistrict product liability litigation.

Read More »